He PL - Search Results

1

Overview of therapeutic drug research for COVID-19 in China.

Li H, Yang L, Liu FF, Ma XN, He PL, Tang W, Tong XK, Zuo JP. Li H, et al. Among authors: he pl. Acta Pharmacol Sin. 2020 Sep;41(9):1133-1140. doi: 10.1038/s41401-020-0438-y. Epub 2020 Jun 17. Acta Pharmacol Sin. 2020. PMID: 32555446 Free PMC article. Review.

2

Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.

He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL, Zhu FH, Tang W, Zuo JP. He SJ, et al. Among authors: he pl. Acta Pharmacol Sin. 2014 Feb;35(2):219-29. doi: 10.1038/aps.2013.167. Epub 2013 Dec 30. Acta Pharmacol Sin. 2014. PMID: 24374810 Free PMC article.

3

Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.

Yang L, Shi LP, Chen HJ, Tong XK, Wang GF, Zhang YM, Wang WL, Feng CL, He PL, Zhu FH, Hao YH, Wang BJ, Yang DL, Tang W, Nan FJ, Zuo JP. Yang L, et al. Among authors: he pl. Acta Pharmacol Sin. 2014 Mar;35(3):410-8. doi: 10.1038/aps.2013.175. Epub 2014 Feb 3. Acta Pharmacol Sin. 2014. PMID: 24487969 Free PMC article.

4

Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease.

Yu Y, Jing JF, Tong XK, He PL, Li YC, Hu YH, Tang W, Zuo JP. Yu Y, et al. Among authors: he pl. Acta Pharmacol Sin. 2014 Aug;35(8):1074-81. doi: 10.1038/aps.2014.55. Epub 2014 Jul 21. Acta Pharmacol Sin. 2014. PMID: 25066323 Free PMC article.

5

Identification of SARS-CoV-2 entry inhibitors among already approved drugs.

Yang L, Pei RJ, Li H, Ma XN, Zhou Y, Zhu FH, He PL, Tang W, Zhang YC, Xiong J, Xiao SQ, Tong XK, Zhang B, Zuo JP. Yang L, et al. Among authors: he pl. Acta Pharmacol Sin. 2021 Aug;42(8):1347-1353. doi: 10.1038/s41401-020-00556-6. Epub 2020 Oct 28. Acta Pharmacol Sin. 2021. PMID: 33116249 Free PMC article.

6

Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions.

Li H, Fan C, Lu H, Feng C, He P, Yang X, Xiang C, Zuo J, Tang W. Li H, et al. Acta Pharm Sin B. 2020 Mar;10(3):447-461. doi: 10.1016/j.apsb.2019.08.006. Epub 2019 Sep 5. Acta Pharm Sin B. 2020. PMID: 32140391 Free PMC article.

7

(5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.

Zhou R, Wang JX, Tang W, He PL, Yang YF, Li YC, Li XY, Zuo JP. Zhou R, et al. Among authors: he pl. Acta Pharmacol Sin. 2006 Dec;27(12):1616-21. doi: 10.1111/j.1745-7254.2006.00457.x. Acta Pharmacol Sin. 2006. PMID: 17112417

8

Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity.

Wan CP, Gao LX, Hou LF, Yang XQ, He PL, Yang YF, Tang W, Yue JM, Li J, Zuo JP. Wan CP, et al. Among authors: he pl. Acta Pharmacol Sin. 2013 Apr;34(4):522-30. doi: 10.1038/aps.2012.208. Epub 2013 Mar 25. Acta Pharmacol Sin. 2013. PMID: 23524573 Free PMC article.

9

Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion.

Xu YB, Yang L, Wang GF, Tong XK, Wang YJ, Yu Y, Jing JF, Feng CL, He PL, Lu W, Tang W, Zuo JP. Xu YB, et al. Among authors: he pl. Antiviral Res. 2014 Jul;107:6-15. doi: 10.1016/j.antiviral.2014.04.002. Epub 2014 Apr 15. Antiviral Res. 2014. PMID: 24746457

10

A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation.

Wang YJ, Lu D, Xu YB, Xing WQ, Tong XK, Wang GF, Feng CL, He PL, Yang L, Tang W, Hu YH, Zuo JP. Wang YJ, et al. Among authors: he pl. Antimicrob Agents Chemother. 2015 Nov;59(11):7061-72. doi: 10.1128/AAC.01558-15. Epub 2015 Sep 8. Antimicrob Agents Chemother. 2015. PMID: 26349829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page